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Abstract
Background: Depression causes a large burden of disease worldwide. Effective prevention has the potential to reduce that
burden considerably. This study aimed to investigate the cost-effectiveness of minimal contact psychotherapy, based on
Lewinsohn’s ‘Coping with depression’ course, targeted at opportunistically screened individuals with sub-threshold
depression.
Methods and Results: Using a Markov model, future health effects and costs of an intervention scenario and a current
practice scenario were estimated. The time horizon was five years. Incremental cost-effectiveness ratios were expressed in
euro per Disability Adjusted Life Year (DALY) averted. Probabilistic sensitivity analysis was employed to study the effect of
uncertainty in the model parameters. From the health care perspective the incremental cost-effectiveness ratio was J 1,400
per DALY, and from the societal perspective the intervention was cost-saving. Although the estimated incremental costs
and effects were surrounded with large uncertainty, given a willingness to pay of J 20,000 per DALY, the probability that
the intervention is cost-effective was around 80%.
Conclusion: This modelling study showed that opportunistic screening in primary care for sub-threshold depression in
combination with minimal contact psychotherapy may be cost-effective in the prevention of major depression.
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Introduction
Depression is a leading cause of burden of disease and health
care costs [1–3]. Worldwide, depression ranks third on the list of
leading causes of burden of disease, causing over 4 percent of all
disability adjusted life years (DALYs), and it is projected to rank
first on this list by 2030 [1,2]. For middle- and high-income
countries, depression was already the leading cause of burden of
disease in 2004, causing over five and eight percent of all DALYs,
respectively [2]. In the Netherlands, almost four percent of the
burden of disease is caused by depression [4], and the 12 month
prevalence of depression is 5.4% [5]. These rates compare to other
European countries [6]. For the Netherlands, it is estimated that
the direct medical costs of depression are 773 million euros (1.1%
of total costs of illness in the Netherlands) [7].
Effective prevention of major depression has the potential to
reduce the burden of disease considerably. Three types of pre-
vention can be discerned, depending on the target group of the
intervention: universal (targeted at entire populations), selective
(targeted at high-risk groups), or indicated (targeted at individuals
with depressive symptoms not meeting all criteria for a depressive
disorder). An important reason for targeting prevention at people
with sub-threshold (minor) depression is that they have an
increased risk of developing major depression compared to
persons not meeting the criteria of sub-threshold depression [8].
In addition, sub-threshold depression is associated with impaired
functioning, reduced quality of life, and excess medical and non-
medical costs [9,10].
Various types of psychotherapy have been evaluated not only to
cure depressive episodes but also to prevent first and further
episodes [11–13]. A recent meta-analysis attributed a statistically
significant reduction of 22% in the incidence of depressive
disorders to psychological interventions [11]. This meta-analysis
included all types of prevention (universal, selective, and indi-
cated). A meta-analysis of indicated prevention of major depres-
sion in individuals with sub-threshold depression only, found a risk
reduction of 30%, but this was not statistically significant [12].
Cognitive behavioural therapy in the form of a ‘Coping with
depression’ course was in several studies found to result in a
reduced risk of getting major depression of 38% [13]. So, effective
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prevention of major depression has the potential to reduce the
burden of disease considerably.
In a Dutch trial, minimal contact psychotherapy, based on
Lewinsohn’s ‘Coping with depression’ course, prevented one third
of the incidence of major depression in individuals with sub-
threshold depression [14]. As this specific delivery format of
the ‘Coping with Depression’ course requires little effort and
therapists’ time, it seems attractive from an economic point of
view. Moreover, the bibliotherapeutical format introduces some
additional benefits: it is a low threshold intervention, with no fear
of stigma involved; it focuses on empowering the participants by
improving self-management skills; and it can be conducted at
times that agree best with the participant’s agenda.
Although the evidence base for effectiveness of depression
prevention is growing, evidence for its cost-effectiveness is still
scarce. To our knowledge, few economic evaluations of preventive
interventions for depression have been published. Smit et al.
evaluated the cost-effectiveness of MCP in costs per avoided major
depression episode, with a one year time horizon, not including
the costs of screening for eligible participants [15]. Lynch et al.
performed an economic evaluation as part of a trial in which the
effectiveness of a CBT course for the prevention of depression in
adolescents with depressed parents [16]. Vos et al. published cost-
effectiveness analyses of several depression interventions, including
relapse prevention by maintenance treatment [17]. In this paper,
we estimated the costs and benefits of opportunistic screening in
general practice and treatment with minimal contact psychother-
apy for individuals with sub-threshold depression to prevent the
incidence of depressive disorders in those individuals.
Materials and Methods
Epidemiological modelling combines available evidence from
different sources and enables predictions of future costs and
benefits. Using a Markov model, we estimated the costs and
benefits of an intervention scenario and a reference scenario
over a five year period. The effectiveness of the intervention was
modelled through a decreased transition probability from sub-
threshold depression to major depression. Disability weight for the
different health states enabled us to calculate the benefits in terms
of DALYs averted. The model combines medical and societal costs
of both minor and major depression, so the cost-effectiveness (in
euros per DALY) of opportunistic screening in general practice for
sub-threshold depressed individuals, and minimal contact psycho-
therapy to prevent depressive disorders in those individuals, was
evaluated both from a health care perspective and from a societal
perspective.
Intervention
The modelled intervention is based on a single trial [14], and
consists of two steps:
1.Opportunistic screening. Persons eligible for the interven-
tion, i.e. persons with sub-threshold depression, were oppor-
tunistically recruited from general practice. First, people in the
waiting room for a GP visit unrelated to depressive symptoms
were approached by the practice assistant. Those who were
eligible for screening and gave informed consent were then
screened for sub-threshold depression (participation rate:
72.5%; screen positive rate: 26.6%). In a second step, screen-
positive patients were approached for follow-up diagnostics in a
clinical interview to exclude those who met criteria for a
depression or anxiety disorder (participation rate: 35.7%;
exclusion rate: 40.5%) [14].
2.Minimal contact psychotherapy. The intervention was
based on Lewinsohn’s ‘Coping with Depression’ course [13],
and consisted of a self-help manual with instructions on
cognitive-behavioural self-help in mood management. The
manual also contains homework assignments aimed at
cognitive restructuring, activity scheduling to increase pleasant
activities and relaxation. Before starting reading the manual, a
brief face-to-face interview with a prevention specialist or a
clinician from a community mental health centre took place.
Thereafter, six short telephone calls (maximum 15 min each)
were offered supporting the participants in working through
the manual. The effect of MCP was a one third decrease of the
incidence rate after 12 months (incidence rate ratio 0.66, 95%
CI 0.40–1.09, significant in the one-sided test) [14].
Scenarios
To estimate the cost-effectiveness of minimal contact psycho-
therapy as indicated prevention of depression, two scenarios were
compared:
N Intervention scenario: all persons in the target population are
screened and those with sub-threshold depression receive
minimal contact psychotherapy.
N Current practice scenario: persons in the target population are
not screened, do not receive minimal contact psychotherapy,
and receive care as usual from their GP.
Target population
In this modelling study, the target population consists of all
people between age 20 and 65 visiting the GP within one year. In
2008, the total Dutch population aged 20–65 years accounted for
about 10 million people. Seventy-two per cent of them (i.e. 7.2
million) visited the GP at least once in that particular year (Statline
database, Statistics Netherlands).
Depression Markov Model
To estimate future health effects and costs a depression Markov
model was developed (Figure 1). The model allows simulating a
cohort of people diagnosed with sub-threshold depression over time
in cycles of four weeks (0–4 weeks, 4–8 weeks, etc.). In every cycle, a
person with sub-threshold depression has a probability to develop
an episode of major depression, or to remain sub-threshold
depressed. We assumed no remission from sub-threshold depression
in the intervention and current practice scenarios. One year-
probability for developing an episode of major depression was
derived from the observed number of events in the control arm of
the trial [14,18]. The one-year probability was transformed into 4-
week probability assuming a constant hazard rate, resulting in a
probability of developing a major depressive episode of 1.6%.
Accordingly, sub-threshold depressed individuals undergoing MCP
(intervention scenario) have a probability to develop a major
depressive episode of 1.1% each cycle of four weeks. It was assumed
that the probability for persons with sub-threshold depression to
develop a major depressive episode does not depend on the time
spent in state but only whether they receive the intervention or not.
The effects of the MCP intervention on major depression incidence
and health care utilization are assumed to last only for one year.
After one year, persons with sub-threshold depression use the same
amount of health services and have the same probability to develop
major depression in both scenarios. Once a person is in a major
depressive episode, this person has a probability to either recover or
to remain depressed in subsequent cycles. The probability to
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recover declines as the length of the episode increases. Once
recovered, people have a probability to relapse into a major
depression, or to remain recovered. There is a difference between
relapse and recurrence. Recurrence can only occur after a person’s
recovery was sustained over 6 months. By contrast, relapse can
occur during remission but before recovery. We collapsed both
health states into a single category, using the term relapse. The
probability to relapse decreases over time. Recovery and relapse
curves were estimated based on data from the Dutch NEMESIS
study, and an Australian modelling study [19,20]. These probability
curves are presented in figure 2. Since the follow up in the trial was
one year, and the time span of both the recovery curve and the
relapse curve was two years, a time horizon of five years was chosen.
DALY’s
Disability weights were derived from the Dutch disability
weights study [21]. Based on this study, the mean disability weight
for major depression was 0.46. Since we did not found a disability
weight for sub-threshold depression in the literature, we used data
from an unpublished study among a small group of Dutch
physicians. Using a calibrated visual analogue scale the mean
disability weight was estimated at 0.097 (95% CI 0.044–0.151)
(Smit et al., unpublished data). Persons recovered from a major
depressive episode were assumed to have the same level of
disability weight as those with sub-threshold depression. DALYs
were calculated by multiplying the time spend in each health state
by the disability weight of that state.
Costs
Intervention costs. As mentioned above, the screening had
two steps. The first screening step, i.e. the actual screening for sub-
threshold depression, was calculated to cost about J5,- per capita.
The second screening step, i.e. the interview with screen-positive
patients to ascertain their diagnostic status and eligibility for the
intervention, costed about J119 per capita. The intervention,
consisting of an intake session, a manual and the phone calls,
costed J423 per capita. All intervention costs were derived from
the economic evaluation of minimal contact psychotherapy as
indicated prevention in primary care [15].
Health care and societal costs. Both health care costs and
societal costs related to sub-threshold depression were based on
Smit et al. Societal costs include costs of informal care, and
productivity losses due to absenteeism [15]. Both health care costs
and societal costs of major depression were based on three Dutch
trials of different therapies for depression in which the costs
associated with major depression were measured for at least one
year [22–24]. Societal costs include costs of informal care [23,24],
productivity losses [22–24], patient costs (e.g. travel time) [24]. In
all studies, productivity costs formed the major part of the societal
costs. The mean health care and societal costs of major depression
were estimated using a random effects meta-analysis of these three
trials. Costs of those recovered from depression were assumed to
be equal to the costs of sub-threshold depression [25]. Mean four
week health care costs and societal costs for different health states
are presented in table 1. All costs were indexed to 2008.
Cost-effectiveness ratio
Incremental cost effectiveness ratios (ICER) are expressed in
euros per DALY averted. In accordance with the Dutch guidelines,
costs were discounted at 4% and effects at 1.5% [26]. The time
horizon was five years. With probabilistic sensitivity analysis (5000
runs), uncertainty in the input parameters was addressed and
reflected in the model output (estimated incremental costs and
DALYs). The distributions used in the probabilistic sensitivity
analysis are shown in table 1. The ICER was calculated as a ratio of
mean incremental costs to mean incremental effects [27].
Results
If trial results [14] were achieved in the whole population, 1.4
million persons would be screened positive for sub-threshold
depression, and 0.3 million persons would receive minimal contact
Figure 1. Graphical representation of the depression Markov model. The model simulates a cohort of people diagnosed with sub-threshold
depression over time in cycles of four weeks.
doi:10.1371/journal.pone.0022884.g001
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psychotherapy (4% of the target population). Table 2 shows the
incremental costs and effects at population level. The mean
incremental health care costs were estimated at J16M (95% CI:
2262M/283M), and the mean incremental total costs (including
societal costs) were a saving of J390M (95% CI:21480M/813M).
The intervention was estimated to avert 12,000 DALYs (95% CI:
29,000/30,000). From the health care perspective, the ICER was
J 1,400 per DALY. From the societal perspective the intervention
was estimated to save costs per averted DALY.
Figure 3 displays cumulative differences in costs and effects
(both discounted) of the intervention scenario compared to the
current practice scenario for different values of the input
parameters over a period of five years. Figure 3 shows that in
both the health care perspective and the societal perspective,
screening and treating sub-threshold depression can result in cost
savings, additional costs, health gains and health losses. The north-
east quadrant represents health gains at additional costs, the south-
east quadrant represents health gains and cost savings, the south-
west quadrant represents health losses and cost saving, and the
north-west quadrant represents health losses at additional costs.
For the health care perspective, the percentages of the points in
these four quadrants were: 47% in the NE, 42% in the SE, 3% in
the SW, and 8% in the NW, respectively. For the societal
perspective these percentages were: 21%, 67%, 9%, and 2%.
Figure 4 displays the cost-effectiveness acceptability curves
(CEAC). A CEAC displays the probability that an intervention is
cost-effective for a range of willingness to pay thresholds. The
probability that screening followed by minimal contact psycho-
therapy, compared to care as usual, is cost-effective increases as
the threshold increases. What can be derived from Figure 4, is that
if we would take the threshold of J 20,000 per DALY, as often
used in the Netherlands [28], the intervention would have a
probability of 79% or 83% to be cost-effective in the health care
perspective or the societal perspective, respectively.
Discussion
This modelling study showed that from a health care
perspective health gains may be achieved cost-effectively if a
screen-and-treat strategy for sub-threshold depression would be
implemented in primary care. From a societal perspective, the
modelled strategy of depression prevention was estimated to result
in cost savings. There were however large uncertainties around the
mean incremental costs and mean incremental effects, and the
Figure 2. Probability curves of recovery from depression (upper graph) and relapse after depression (lower graph).
doi:10.1371/journal.pone.0022884.g002
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probabilistic sensitivity analysis resulted in estimates in all four
quadrants of the cost-effectiveness plane.
Strengths
Although the evidence base for effectiveness of depression
prevention is growing, evidence for its cost-effectiveness is still
scarce. To our knowledge, few economic evaluations of preventive
interventions for depression have been published [15–17]. Smit et
al. evaluated the cost-effectiveness of minimal contact psychother-
apy in costs per avoided major depression episode, with a one year
time horizon, not including the costs of screening for eligible
participants [15]. In our model, the outcome measure was
expressed in DALYs, a five year time horizon was used, and all
relevant costs were included. Moreover, the economic evaluation
was performed using both the health care perspective and the
societal perspective. Although the intervention was cost-effective in
both perspectives, large differences were found. From the health
care perspective money needs to be invested to realise health gain,
while from the societal perspective it was estimated that the
intervention generates both health gain and costs savings.
Substantial costs associated with depression (e.g. productivity
losses) are not taken into account using a health care perspective.
This underlines the necessity of incorporating all relevant costs and
Table 1. Distributions of the model parameters used in the probabilistic sensitivity analysis and point estimates with confidence
intervals between brackets.
Reference scenario Intervention scenario
Screening process Fraction of the target population that
agrees to be screened
Beta distributiona (alfa = 3826;
beta = 1452) 0.725 (0.713–0737)
Fraction of screened included for
diagnostic interview
Beta distributiona (alfa = 364;
beta = 3463) 0.095 (0.086–0.105)
Fraction of interviewed included
in intervention
Beta distributiona (alfa = 217;
beta = 148) 0.595 (0.544–0.645)
Sub threshold states Incidence probability from sub-threshold
to major depression
Beta distributionb (alfa = 21;
beta = 90) 0.016 (0.010–0.023)
Beta distributionb (alfa = 14;
beta = 95) 0.011 (0.06–0.017)
Health care costs for sub-threshold
depression
Gamma distributionc (alfa = 15;
beta = 108) 132 (73–207)
Gamma distributionc (alfa = 31;
beta = 55) 139 (94–192)
Total costs for sub-threshold
depression
Gamma distributionc (alfa = 33;
beta = 258) 439 (219–691)
Gamma distributionc (alfa = 16;
beta = 433) 384 (138–692)
Quality of life for sub-threshold
depression
Beta distributiond (alfa = 106;
beta = 11) 0.906 (0.847–0.952)
Same as No MCP
Major depression states Health care costs for major
depression
Gamma distributione (alfa = 13;
beta = 11) 268 (150–419)
Same as No MCP
Total costs for major depression Gamma distributione(alfa = 14;
beta = 26) 615 (308–1022)
Same as No MCP
Recovered from major
depression states
Health care costs in those recovered
from major depression
Same as health care costs in sub-
threshold depression states
Same as No MCP
Total costs in those recovered from
major depression
Same as health care costs in sub-
threshold depression states
Same as No MCP
Quality of life in those recovered
from major depression
Same as QoL in sub-threshold
depression states
Same as No MCP
aDerived from observed number of events [14,18].
bOne year-probabilities were derived from observed number of events [14,18]. One-year probabilities were transformed into 4-week probabilities assuming a constant
hazard rate.
cYearly costs derived from Smit et al. using method of moments [15]. Yearly costs were divided by 13 and multiplied by price indices to obtain costs per cycle. Societal
costs include health care costs but exclude the costs of work cut-back as reported in Smit et al. [15] as these were not included in the studies used to estimate societal
costs associated with major depression [20–22].
dDistribution was derived from a sample of Dutch physicians’ estimation of the utility of sub-threshold depression (0.903, 95%CI 0.849–0.956) (Smit et al., unpublished
study).
eYearly costs derived using random effect meta analyses from 3 studies [20–22]. Yearly costs were divided by 13 and multiplied by price indices to obtain costs per cycle.
Societal costs include health care costs.
doi:10.1371/journal.pone.0022884.t001
Table 2. Estimates of total incremental costs and effects in
the target populationa.
Incremental health care costs (J Millions )c 16 ( 2262/283)
Screening costs 54 (50/59)
Costs of the intervention 42 (36/47)
Other health care expenditures 280 (2360/186)
Incremental societal costs (J Millions)c 2 390 (21480/813)
Incremental DALYs averted (thousands)b 12 (29/30)
Incremental cost-effectiveness ratio, health care
perspective (J per DALY)
1,400
Incremental cost-effectiveness ratio, societal
perspective (J per DALY)
Cost saving
aIntervention scenario compared to reference scenario (95% confidence
intervals between brackets).
bDiscounted with 1.5%.
cDiscounted with 4%.
doi:10.1371/journal.pone.0022884.t002
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effects in economic evaluations. Finally, this study modelled
minimal contact psychotherapy as the preventive intervention of
choice, while other delivery formats of Lewinsohn’s Coping (e.g.
online intervention, and face-to-face intervention) are also
available in the Netherlands. We believe that it is important to
have different delivery formats available, such that the intervention
can be offered in a format that matches the preferences and
capacities of the individual patient in the best possible way.
Limitations
As in any modelling study, we made some simplifying assump-
tions that deserve further research. Most importantly, we assumed
that the effectiveness of the intervention would last for only one
year. Furthermore, persons with sub-threshold depression who do
not develop a major depressive episode within a year would
remain at risk for major depression. So, we assumed no remission
from sub-threshold depression. The disability weight for sub-
threshold depression was based on a small, unpublished study.
Higher disability weights for sub-threshold depression would result
in slightly smaller health gains in the intervention scenario, and in
a somewhat higher cost-effectiveness ratio. For instance, with a
disability weight of 0.19, which equals the disability weight of mild
major depression [21], the ICER stays below J2.000 per DALY
averted (health care perspective). We also assumed that the
disability weight for persons recovered from major depression is
equal to the weight for persons with sub-threshold depression.
Moreover, although having a disease history of depressive episodes
affects ones future risk, we did not make adjustments for disease
history in the model. And although the risk of relapse or recur-
rence increases with the number of previous depressive episodes
[29], relapse probabilities were not modelled to depend on number
of previous episodes of major depression. A constant hazard rate
was used for the transformation of the one year probability of
developing a major depressive episode into a four week probability.
So, in the model, the probability for persons with sub-threshold
Figure 3. Incremental effects and incremental costs of the intervention scenario vs. the reference scenario from the health care
perspective and the societal perspective.
doi:10.1371/journal.pone.0022884.g003
Figure 4. Cost-effectiveness acceptability curves for the health
care perspective and the societal perspective.
doi:10.1371/journal.pone.0022884.g004
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depression to develop a major depressive episode did not depend on
the time spent in the state but only whether they receive the
intervention or not. It might however be the case that the longer one
has sub-threshold depression, the more likely that major depression
will supervene.
We did take into account the uncertainty around a lot of model
parameters. Nevertheless, the uncertainty around some important
parameters (e.g. relapse probabilities, and health care costs of
those just recovered from depression) could not be assessed.
Additional uncertainty may influence the estimates of the cost
effectiveness ratio. Furthermore, assumptions concerning the
effectiveness of minimal contact psychotherapy were based on a
single trial, carried out in the Netherlands. The trial was
underpowered, and the incidence risk ratio that was only
significantly different from 1 in the one-sided test. Although this
is indeed a rather small evidence base, meta-analyses on the
effectiveness of psychotherapy in the prevention of depression
show comparable effectiveness with incidence risk ratios between
0.62 and 0.78, significant in two-sided tests [11–13]. We incor-
porated the uncertainty surrounding the intervention’s effective-
ness in the probabilistic sensitivity analysis. This is reflected in the
broad 95% confidence intervals of the estimated incremental
benefits and costs. Based on the trial, we also assumed that every
positive screen was followed by a diagnostic interview to exclude
major depression or anxiety disorders. However, in everyday
practice such a double check would be unrealistic. Depression is
associated with increased mortality rates. However, since the trial
from which we derived the effectiveness figures did not include
mortality as an outcome measure, we did not include this
parameter in the Markov model. By excluding this outcome, the
results present an underestimation of the real cost-effectiveness of
this intervention. Finally, we assumed that in the intervention
scenario every patient visiting a general practitioner will be
screened for sub-threshold depression. This assumption was a
direct extrapolation from the effectiveness trial [14]. The feasibility
of screening all GP patients can be questioned. Targeting selective
screening to specific settings (e.g. nursing homes, hospitals, schools)
or high-risk groups (e.g. people exposed to risk factors such as
chronic illness, poverty, widowhood, small social networks) might
offer a more pragmatic approach. It is worth noting that applying
a lower proportion of people being screened would affect both the
numerator and the denominator of the ICER in the same degree,
leaving the conclusion concerning the cost-effectiveness un-
changed; but would affect the estimate of the total health gain in
the population as well as the total intervention costs.
Conclusion
In conclusion, opportunistic screening of primary care patients
and treating those with sub-threshold depression with an
intervention that reduces the risk of developing a full-blown
depression with one third could save costs to society.
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